Diphenylhydantoin Induced Severe Gingival Hyperplasia

  • Sheikh Saleem Department of Neurology SKIMS
  • Sawan Verma Department of Neurology SKIMS
  • Irfan Yousuf Department of Neurology SKIMS
  • Mushtaq Ahmad Wani Department of Neurology SKIMS
  • Ravouf Asmi Department of Neurology SKIMS

Resumen

Gingival overgrowth (GO) is a side effect, associated with some distinct classes of drugs, such as anticonvulsants, immunosuppressant, and calcium channel blockers. One of the main drugs associated with GO is the antiepileptic, diphenylhydantoin (DPH)/ phenytoin (1), which affects gingival tissues by altering extracellular matrix metabolism. Phenytoin (DPH)-induced gingival overgrowth (PIGO) due to chronic administration remains an unsolved problem especially in cases where this drug is taken without any supervision due usually to poor follow-up. Younger age groups experience more lesions than adults and in the mentally handicapped the prevalence appears to be highest. The most satisfactory treatment is the replacement of the drug by a safer antiepileptic. Patients who are to be maintained on DPH respond well to a program of meticulous oral hygiene at home along with frequent professional prophylaxes. We present a case of seizure disorder with mental retardation who developed severe gingival overgrowth wherein teeth are almost buried, caused by unsupervised intake of phenytoin. JMS 2017; 20(1):44-46

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Sheikh Saleem, Department of Neurology SKIMS

Prof.

Publicado
2017-06-16
Cómo citar
1.
Saleem S, Verma S, Yousuf I, Wani M, Asmi R. Diphenylhydantoin Induced Severe Gingival Hyperplasia. jms [Internet]. 16 de junio de 2017 [citado 19 de noviembre de 2026];20(1):44-6. Disponible en: http://ano.jmsskims.org/index.php/jms/article/view/311
Sección
Case Reports

##plugins.generic.recommendByAuthor.heading##